Constitutive activation of the DNA damage response pathway as a novel therapeutic target in diffuse large B-cell lymphoma
Enrico Derenzini(The University of Texas MD Anderson Cancer Center), Pier Luigi Zinzani(University of Bologna)
Cited by 58
Related Papers
The JAK inhibitor AZD1480 regulates proliferation and immunity in Hodgkin lymphoma
|Blood Cancer Journal|2011|70